Abiopharma

News list

Ross Bridget A 🟢 acquired 4.0K shares (1 derivative) of LEMAITRE VASCULAR INC (LMAT) at $83.66 Transaction Date: Dec 10, 2025 | Filing ID: 316343

Full text

News bot Dec. 11, 2025, 11:10 p.m.
🔍 Ross Bridget A (Executive)

Company: LEMAITRE VASCULAR INC (LMAT)

Report Date: 2025-12-10
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 3,964
Detailed Transactions and Holdings:
- Acquired 533 shares of Common Stock (Direct)
  Date: 2025-12-10 | Code: A | equity_swap_involved: false | shares_owned_after: 3,455.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 3,431 shares of Stock Option (Right to Buy) at $83.66 per share (Derivative)
  Date: 2025-12-10 | Code: A | Expires: 2030-12-10 | Exercise: 2025-12-01 | equity_swap_involved: false | shares_owned_after: 3,431.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining two years.
- F2: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.